Skip to content

13F-HR filed by SPHERA FUNDS MANAGEMENT LTD.

SPHERA FUNDS MANAGEMENT LTD. filed this 13F-HR for the quarter ended 2016-06-30, filed 2016-08-10, with 91 holding rows worth $385,161,000.

Accession
0001178913-16-006167
Filed
2016-08-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2016

A holdings report, 91 entries on the cover page, a total value of $385,161,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $385,166,000 with VALUE read as thousands by filing date, 13F file number 028-15863. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR600,200$30,148,000thousands by filing date
ALLERGAN PLCG0177J108SHS95,000$21,954,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO264,539$21,599,000thousands by filing date
Gilead Sciences,Inc.375558103COM192,700$16,075,000thousands by filing date
Eli Lilly and Company532457108COM200,000$15,750,000thousands by filing date
CELGENE CORP151020104COM155,000$15,288,000thousands by filing date
Pfizer Inc.717081103COM426,612$15,021,000thousands by filing date
AMGEN INC.31162100 COM85,000$12,933,000thousands by filing dateThe CUSIP as filed is malformed.
BIOGEN INC COM09062X103Stock50,500$12,212,000thousands by filing date
MYLAN NVN59465109SHS EURO250,000$10,810,000thousands by filing date
ITURAN LOCATION AND CONTROL SHSM6158M104Stock460,452$10,448,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR398,287$6,391,000thousands by filing date
BIOGEN INC09062X953COM250$6,046,000thousands by filing dateput
Merck & Co.,Inc.58933Y105COM100,000$5,761,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM1,005,000$5,487,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM718,080$5,220,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM105,000$5,136,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM57,600$4,955,000thousands by filing date
ALEXION PHARMACEUTICALS IN15351109 COM42,323$4,942,000thousands by filing dateThe CUSIP as filed is malformed.
ACADIA HEALTHCARE COMPANY IN00404A909COM1,500$4,869,000thousands by filing datecall
ACHAOGEN INC4449104 COM1,257,366$4,765,000thousands by filing dateThe CUSIP as filed is malformed.
CORVUS PHARMACEUTICALS INC221015100COM325,053$4,577,000thousands by filing date
ADVANCE AUTO PARTS INC00751Y106COM27,662$4,471,000thousands by filing date
NEURODERM LTDM74231107ORD SHS258,513$4,201,000thousands by filing date
GILEAD SCIENCES INC375558903COM500$4,171,000thousands by filing datecall
ADAMAS PHARMACEUTICALS INC00548A106COM270,000$4,088,000thousands by filing date
COLUCID PHARMACEUTICALS INC19716T101COM500,137$4,086,000thousands by filing date
TESARO INC881569907CALL450$3,782,000thousands by filing datecall
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK562,900$3,726,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM16,065$3,673,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS40,000$3,663,000thousands by filing date
B COMMUNICATIONS LTDM15629104SHS148,861$3,556,000thousands by filing date
MACROGENICS INC556099109COM130,000$3,509,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR261,800$3,474,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC02043Q957COM600$3,329,000thousands by filing dateput
RADIUS HEALTH INC750469207COM NEW90,000$3,308,000thousands by filing date
SAGE THERAPEUTICS INC78667J908COM1,000$3,013,000thousands by filing datecall
EIGER BIOPHARMACEUTICALS INC28249U105COM150,716$2,987,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM4,162$2,928,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM709,271$2,908,000thousands by filing date
GW PHARMACEUTICALS PLC36197T903CALL310$2,839,000thousands by filing datecall
Visa Inc92826C839COM37,966$2,816,000thousands by filing date
Alder Biopharmaceuticals Inc.14339105 Com112,500$2,809,000thousands by filing dateThe CUSIP as filed is malformed.
CLOVIS ONCOLOGY INC189464100COM200,000$2,744,000thousands by filing date
RETROPHIN INC761299106COM150,000$2,672,000thousands by filing date
KITE PHARMA INC49803L109COM50,000$2,500,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM98,000$2,499,000thousands by filing date
Medgenics Inc New58436Q203COM NEW450,000$2,498,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock60,000$2,481,000thousands by filing date
RELYPSA INC759531106Common Stock130,000$2,405,000thousands by filing date
ENDO INTL PLCG30401106SHS150,000$2,339,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR134,037$2,245,000thousands by filing date
FORWARD PHARMA A/S34986J105SPONSORED ADR121,500$2,208,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS342,000$2,172,000thousands by filing date
ORBOTECH LTDM75253100ORD84,210$2,152,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM300,000$2,103,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM368,500$2,097,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM69,500$2,094,000thousands by filing date
DERMIRA INC24983L104COM70,000$2,048,000thousands by filing date
DBV TECHNOLOGIES S A23306J101ADR60,611$1,977,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity140,000$1,947,000thousands by filing date
CHINOOK THERAPEUTICS INC.00739L101Common Stock170,000$1,923,000thousands by filing date
Rocket Pharmaceuticals Inc45780V102SHS250,000$1,860,000thousands by filing date
BLUEBIRD BIO INC09609G100COM40,000$1,732,000thousands by filing date
SUMMIT THERAPEUTICS INC COM86627R102Stock197,450$1,562,000thousands by filing date
EDGE THERAPEUTICS INC279870109COM150,000$1,517,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM1,170,643$1,487,000thousands by filing date
EGALET CORP28226B104COM292,500$1,451,000thousands by filing date
FIBROGEN INC31572Q808COM85,700$1,406,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM68,500$1,380,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM810,000$1,304,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock153,000$1,248,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM174,461$1,225,000thousands by filing date
TRILLIUM THERAPEUTICS INC COM NEW89620X506Stock132,300$1,188,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM294,100$1,147,000thousands by filing date
SERVICEMASTER GLOBAL HOLDING81761R109COMMON STOCK27,750$1,104,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value300,000$1,044,000thousands by filing date
CERULEAN PHARMA INC15708Q105COM450,000$954,000thousands by filing date
IMMUNOMEDICS INC452907108COM400,000$928,000thousands by filing date
ONCOBIOLOGICS INC68235M105COM259,000$881,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS50,000$823,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM150,000$819,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM203,243$752,000thousands by filing date
SAPIENS INTERNATIONAL CORPN7716A151SHS60,949$714,000thousands by filing date
PALATIN TECHNOLOGIES INC696077403COM PAR $ .011,015,374$448,000thousands by filing date
ABEONA THERAPEUTICS INC00289Y107COM138,105$326,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW32,069$304,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock128,500$279,000thousands by filing date
INSYS THERAPEUTICS INC45824V209COMMON STOCK16,407$212,000thousands by filing date
ISHARES TR464287955PUT2,000$200,000thousands by filing dateput
ELLOMAY CAPITAL LIMITEDM39927120SHS5,653$43,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001178913-16-006167this filing2016-08-10acceptance time not in the bulk data set